| Literature DB >> 25921670 |
Ali Habib1, Kush Desai1, Ryan Hickey1, Bartley Thornburg1, Robert Lewandowski1, Riad Salem2.
Abstract
Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.Entities:
Keywords: Hepatocellular carcinoma; Interventional oncology; Locoregional therapies; Percutaneous ethanol injection; Radioembolization; Radiofrequency ablation; Transarterial chemoembolization; Transplantation
Mesh:
Substances:
Year: 2015 PMID: 25921670 DOI: 10.1016/j.cld.2015.01.008
Source DB: PubMed Journal: Clin Liver Dis ISSN: 1089-3261 Impact factor: 6.126